Literature DB >> 24480025

Summary and recommendations from a National Institute of Allergy and Infectious Diseases (NIAID) workshop on "Next Generation Herpes Simplex Virus Vaccines".

David M Knipe1, Lawrence Corey2, Jeffrey I Cohen3, Carolyn D Deal4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24480025      PMCID: PMC4786164          DOI: 10.1016/j.vaccine.2014.01.052

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  11 in total

1.  Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.

Authors:  Arif A Khan; Ruchi Srivastava; Aziz A Chentoufi; Roger Geertsema; Nhi Thi Uyen Thai; Gargi Dasgupta; Nelson Osorio; Mina Kalantari; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

2.  Vaccination to Reduce Reactivation of Herpes Simplex Virus Type 2.

Authors:  Jeffrey I Cohen
Journal:  J Infect Dis       Date:  2017-03-15       Impact factor: 5.226

3.  Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.

Authors:  Sarah Samandary; Hédia Kridane-Miledi; Jacqueline S Sandoval; Zareen Choudhury; Francina Langa-Vives; Doran Spencer; Aziz A Chentoufi; François A Lemonnier; Lbachir BenMohamed
Journal:  Hum Immunol       Date:  2014-05-04       Impact factor: 2.850

4.  Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity.

Authors:  Chaya D Patel; Iara M Backes; Sean A Taylor; Yike Jiang; Arnaud Marchant; Jean M Pesola; Donald M Coen; David M Knipe; Margaret E Ackerman; David A Leib
Journal:  Sci Transl Med       Date:  2019-04-10       Impact factor: 17.956

Review 5.  The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine.

Authors:  Tiffany Kuo; Christine Wang; Tina Badakhshan; Sravya Chilukuri; Lbachir BenMohamed
Journal:  Vaccine       Date:  2014-10-16       Impact factor: 3.641

6.  A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model.

Authors:  Ruchi Srivastava; Arif A Khan; Jiawei Huang; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

7.  Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes.

Authors:  Arif A Khan; Ruchi Srivastava; Doran Spencer; Sumit Garg; Daniel Fremgen; Hawa Vahed; Patricia P Lopes; Thanh T Pham; Charlie Hewett; Jasmine Kuang; Nicolas Ong; Lei Huang; Vanessa M Scarfone; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

Review 8.  The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps.

Authors:  Sami L Gottlieb; Carolyn D Deal; Birgitte Giersing; Helen Rees; Gail Bolan; Christine Johnston; Peter Timms; Scott D Gray-Owen; Ann E Jerse; Caroline E Cameron; Vasee S Moorthy; James Kiarie; Nathalie Broutet
Journal:  Vaccine       Date:  2016-04-19       Impact factor: 3.641

9.  Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus.

Authors:  Fernando M Diaz; David M Knipe
Journal:  Virology       Date:  2015-11-21       Impact factor: 3.616

Review 10.  Future prospects for new vaccines against sexually transmitted infections.

Authors:  Sami L Gottlieb; Christine Johnston
Journal:  Curr Opin Infect Dis       Date:  2017-02       Impact factor: 4.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.